The DOI matches its Crossref record; 751 of the 751 references it cites were found in a registry or an index.
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Open accessAbstract
Alzheimer disease (AD) is associated with multiple etiologies and pathological mechanisms, among which oxidative stress (OS) appears as a major determinant. Intriguingly, OS arises in various pathways regulating brain functions, and it seems to link different hypotheses and mechanisms of AD neuropathology with high fidelity. The brain is particularly vulnerable to oxidative damage, mainly because of its unique lipid composition, resulting in an amplified cascade of redox reactions that target several cellular components/functions ultimately leading to neurodegeneration. The present review highlights the “OS hypothesis of AD,” including amyloid beta-peptide-associated mechanisms, the role of lipid and protein oxidation unraveled by redox proteomics, and the antioxidant strategies that have been investigated to modulate the progression of AD. Collected studies from our groups and others have contributed to unraveling the close relationships between perturbation of redox homeostasis in the brain and AD neuropathology by elucidating redox-regulated events potentially involved in both the pathogenesis and progression of AD. However, the complexity of AD pathological mechanisms requires an in-depth understanding of several major intracellular pathways affecting redox homeostasis and relevant for brain functions. This understanding is crucial to developing pharmacological strategies targeting OS-mediated toxicity that may potentially contribute to slow AD progression as well as improve the quality of life of persons with this severe dementing disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 751
Klyubin, I., Betts, V., Welzel, A. T., Blennow, K., Zetterberg, H., Wallin, A., Lemere, C. A., Cullen, W. K., Peng, Y., Wisniewski, T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5161-07.2008 · Cited by 321
Almeida, C. G., Takahashi, R. H., & Gouras, G. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5078-05.2006 · Cited by 316
de la Monte, S. M., & Wands, J. R. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9209 · Cited by 316
Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease
Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., Maniar, K., Dolios, G., Wang, R., Hof, P. R., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3182fje · Cited by 316
Alavi Naini, S. M., & Soussi-Yanicostas, N. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/151979 · Cited by 316
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Singh, N. A., Mandal, A. K. A., & Khan, Z. A. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0179-4 · Cited by 314
Mao, P., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.005 · Cited by 313
Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
Persson, T., Popescu, B. O., & Cedazo-Minguez, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/427318 · Cited by 312
F2-Isoprostanes as markers of oxidative stress in vivo: An overview
Milne, G. L., Musiek, E. S., & Morrow, J. D. (2005) · Biomarkers · doi:10.1080/13547500500216546 · Cited by 312
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Sex differences in cognitive impairment in Alzheimer’s disease
Laws, K. R., Irvine, K., & Gale, T. M. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i1.54 · Cited by 307
Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases
Goedert, M., Hasegawa, M., Jakes, R., Lawler, S., Cuenda, A., & Cohen, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00483-3 · Cited by 305
Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons
Tangney, C. C., Li, H., Wang, Y., Barnes, L., Schneider, J. A., Bennett, D. A., & Morris, M. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000884 · Cited by 304
Reddy, P. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.052 · Cited by 304
Oxidative stress, protein modification and Alzheimer disease
Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303
Self-citationButterfield, D. A., Bader Lange, M. L., & Sultana, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.005 · Cited by 299
Self-citationDown syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 299
Sung, S., Yao, Y., Uryu, K., Yang, H., Lee, V. M. ‐., Trojanowski, J. Q., & Praticò, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0961fje · Cited by 298
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
Kryscio, R. J., Abner, E. L., Caban-Holt, A., Lovell, M., Goodman, P., Darke, A. K., Yee, M., Crowley, J., & Schmitt, F. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5778 · Cited by 295
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293
Aberrant insulin signaling in Alzheimer's disease: current knowledge
Bedse, G., Di Domenico, F., Serviddio, G., & Cassano, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00204 · Cited by 292
Self-citationAging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Head, E., T. Lott, I., M. Wilcock, D., & A. Lemere, C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666151020114607 · Cited by 289
Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.
Scheff, S. W., & Price, D. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s312 · Cited by 284
van Eersel, J., Ke, Y. D., Liu, X., Delerue, F., Kril, J. J., Götz, J., & Ittner, L. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009038107 · Cited by 284
Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics
Paul, B. D., Snyder, S. H., & Kashfi, K. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101772 · Cited by 284
Physical activity and brain plasticity in late adulthood
Erickson, K. I., Gildengers, A. G., & Butters, M. A. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.1/kerickson · Cited by 284
Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280
Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Sultana, R., Ravagna, A., Mohmmad‐Abdul, H., Calabrese, V., & Butterfield, D. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02899.x · Cited by 276
Self-citationAutophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain
Keller, J. N., Dimayuga, E., Chen, Q., Thorpe, J., Gee, J., & Ding, Q. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.003 · Cited by 271
Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270
Self-citationGiraldo, E., Lloret, A., Fuchsberger, T., & Viña, J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.002 · Cited by 268
Butterfield, D. A., & Boyd-Kimball, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267
Self-citationMitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Cai, Q., & Jeong, Y. Y. (2020) · Cells · doi:10.3390/cells9010150 · Cited by 265
Sultana, R., Perluigi, M., & Butterfield, D. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2021 · Cited by 262
Self-citationDietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8
Porquet, D., Casadesús, G., Bayod, S., Vicente, A., Canudas, A. M., Vilaplana, J., Pelegrí, C., Sanfeliu, C., Camins, A., Pallàs, M., et al. (2013) · AGE · doi:10.1007/s11357-012-9489-4 · Cited by 262
Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257
Self-citationDhawan, S., Kapil, R., & Singh, B. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01225.x · Cited by 256
Protein damage, repair and proteolysis
Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., Grune, T., & Gonos, E. S. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.09.001 · Cited by 256
Mecocci, P., Boccardi, V., Cecchetti, R., Bastiani, P., Scamosci, M., Ruggiero, C., & Baroni, M. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170732 · Cited by 256
Di Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Self-citationSultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 253
Self-citationAlzheimer’s pathogenic mechanisms and underlying sex difference
Zhu, D., Montagne, A., & Zhao, Z. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03830-w · Cited by 250
Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246
Self-citationThe Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Joshi, G., & A. Johnson, J. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803252023 · Cited by 246
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP
Doran, E., Keator, D., Head, E., Phelan, M. J., Kim, R., Totoiu, M., Barrio, J. R., Small, G. W., Potkin, S. G., & Lott, I. T. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160836 · Cited by 244
Ron, D., & Hubbard, S. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.017 · Cited by 244
Soininen, H., Solomon, A., Visser, P. J., Hendrix, S. B., Blennow, K., Kivipelto, M., Hartmann, T., Hallikainen, I., Hallikainen, M., Helisalmi, S., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30332-0 · Cited by 241
Mediterranean Diet, Inflammatory and Metabolic Biomarkers, and Risk of Alzheimer's Disease
Gu, Y., Luchsinger, J. A., Stern, Y., & Scarmeas, N. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100897 · Cited by 241
Yatin, S. M., Varadarajan, S., & Butterfield, D. A. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-2212 · Cited by 239
Self-citationRyan, N. S., Nicholas, J. M., Weston, P. S. J., Liang, Y., Lashley, T., Guerreiro, R., Adamson, G., Kenny, J., Beck, J., Chavez-Gutierrez, L., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30193-4 · Cited by 239
Ahmed, N., Ahmed, U., Thornalley, P. J., Hager, K., Fleischer, G., & Münch, G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02864.x · Cited by 238
Oxidized messenger RNA induces translation errors
Tanaka, M., Chock, P. B., & Stadtman, E. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609737104 · Cited by 237
Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Markesbery, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1220 · Cited by 236
Glutathione redox imbalance in brain disorders
Gu, F., Chauhan, V., & Chauhan, A. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000134 · Cited by 236
Raynes, R., Pomatto, L. C. D., & Davies, K. J. A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.05.001 · Cited by 235
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Vegeto, E., Villa, A., Della Torre, S., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A., & Poletti, A. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 232
Requejo, R., Hurd, T. R., Costa, N. J., & Murphy, M. P. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07576.x · Cited by 231
Role of thiols in oxidative stress
Baba, S. P., & Bhatnagar, A. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.03.005 · Cited by 230
Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease
Mecocci, P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.794 · Cited by 229
Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
Sokolov, Y., Kozak, J. A., Kayed, R., Chanturiya, A., Glabe, C., & Hall, J. E. (2006) · The Journal of General Physiology · doi:10.1085/jgp.200609533 · Cited by 228
Neurological phenotypes for Down syndrome across the life span
Lott, I. T. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-54299-1.00006-6 · Cited by 225
Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers
Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.008 · Cited by 223
Ali, T., & Kim, M. O. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12238 · Cited by 223
Lloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1033 · Cited by 222
Huang, T.-C., Lu, K.-T., Wo, Y.-Y. P., Wu, Y.-J., & Yang, Y.-L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029102 · Cited by 217
Health Benefits of Fasting and Caloric Restriction
Golbidi, S., Daiber, A., Korac, B., Li, H., Essop, M. F., & Laher, I. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0951-7 · Cited by 217
Claxton, A., Baker, L. D., Wilkinson, C. W., Trittschuh, E. H., Chapman, D., Watson, G. S., Cholerton, B., Plymate, S. R., Arbuckle, M., & Craft, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-122308 · Cited by 215
Lavie, C. J., Church, T. S., Milani, R. V., & Earnest, C. P. (2011) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e3182122827 · Cited by 215
Leverenz, J. B., & Raskind, M. A. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6777 · Cited by 214
Lu, Y., Dong, Y., Tucker, D., Wang, R., Ahmed, M. E., Brann, D., & Zhang, Q. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160869 · Cited by 214
Bahn, G., Park, J.-S., Yun, U. J., Lee, Y. J., Choi, Y., Park, J. S., Baek, S. H., Choi, B. Y., Cho, Y. S., Kim, H. K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819541116 · Cited by 210
Montgomery, S. A., Thal, L. J., & Amrein, R. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00001 · Cited by 209
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
Proitsi, P., Kim, M., Whiley, L., Simmons, A., Sattlecker, M., Velayudhan, L., Lupton, M. K., Soininen, H., Kloszewska, I., Mecocci, P., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.003 · Cited by 209
Milgram, N. W., Head, E., Zicker, S. C., Ikeda-Douglas, C. J., Murphey, H., Muggenburg, B., Siwak, C., Tapp, D., & Cotman, C. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.014 · Cited by 208
Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates
Park, H., Kang, J.-H., & Lee, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093369 · Cited by 207
Pham, E., Crews, L., Ubhi, K., Hansen, L., Adame, A., Cartier, A., Salmon, D., Galasko, D., Michael, S., Savas, J. N., et al. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07719.x · Cited by 206
Nucleic acid oxidation in Alzheimer disease
Moreira, P. I., Nunomura, A., Nakamura, M., Takeda, A., Shenk, J. C., Aliev, G., Smith, M. A., & Perry, G. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.002 · Cited by 206
Modeling Alzheimer’s disease in transgenic rats
Do Carmo, S., & Cuello, A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-37 · Cited by 206
Reitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.297 · Cited by 205
General Principals of miRNA Biogenesis and Regulation in the Brain
O'Carroll, D., & Schaefer, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.87 · Cited by 205
Lovell, M. A., Xiong, S., Xie, C., Davies, P., & Markesbery, W. R. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6610 · Cited by 204
Opii, W. O., Joshi, G., Head, E., Milgram, N. W., Muggenburg, B. A., Klein, J. B., Pierce, W. M., Cotman, C. W., & Butterfield, D. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.012 · Cited by 202
Self-citationIncreased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients
Mullaart, E., Boerrigter, M. E. T. I., Ravid, R., Swaab, D. F., & Vijg, J. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90542-8 · Cited by 201
Ishrat, T., Parveen, K., Khan, M. M., Khuwaja, G., Khan, M. B., Yousuf, S., Ahmad, A., Shrivastav, P., & Islam, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.010 · Cited by 199
Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s disease
Sun, D., Li, N., Zhang, W., Zhao, Z., Mou, Z., Huang, D., Liu, J., & Wang, W. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.08.052 · Cited by 199
Glucose, glycolysis, and neurodegenerative diseases
Tang, B. L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29682 · Cited by 199
Schöneich, C., Pogocki, D., Hug, G. L., & Bobrowski, K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036733b · Cited by 198
Perluigi, M., Sultana, R., Cenini, G., Di Domenico, F., Memo, M., Pierce, W. M., Coccia, R., & Butterfield, D. A. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800161 · Cited by 196
Self-citationLee, Y.-J., Choi, D.-Y., Yun, Y.-P., Han, S. B., Oh, K.-W., & Hong, J. T. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.011 · Cited by 195
Wang, D.-M., Li, S.-Q., Wu, W.-L., Zhu, X.-Y., Wang, Y., & Yuan, H.-Y. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1343-x · Cited by 195
Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 195
Fontán-Lozano, Á., Sáez-Cassanelli, J. L., Inda, M. C., de los Santos-Arteaga, M., Sierra-Domínguez, S. A., López-Lluch, G., Delgado-García, J. M., & Carrión, Á. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2757-07.2007 · Cited by 195
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Müller, C. E., Buée, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.027 · Cited by 195
Effect of lifestyle activities on alzheimer disease biomarkers and cognition
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Roberts, R. O., Lowe, V. J., Kantarci, K., Senjem, M. L., Gunter, J. L., Boeve, B. F., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23665 · Cited by 193
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
Höhn, A., Tramutola, A., & Cascella, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5497046 · Cited by 192
Dragicevic, N., Mamcarz, M., Zhu, Y., Buzzeo, R., Tan, J., Arendash, G. W., & Bradshaw, P. C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100342 · Cited by 191
Mediterranean Diet and Cardiovascular Risk Factors: A Systematic Review
Grosso, G., Mistretta, A., Frigiola, A., Gruttadauria, S., Biondi, A., Basile, F., Vitaglione, P., D’Orazio, N., & Galvano, F. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.596955 · Cited by 191
Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190
Mori, T., Koyama, N., Guillot-Sestier, M.-V., Tan, J., & Town, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055774 · Cited by 189
Valenti, D., de Bari, L., De Filippis, B., Henrion-Caude, A., & Vacca, R. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.012 · Cited by 189
Butterfield, D. A., Galvan, V., Lange, M. B., Tang, H., Sowell, R. A., Spilman, P., Fombonne, J., Gorostiza, O., Zhang, J., Sultana, R., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.035 · Cited by 188
Self-citationApolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
Butterfield, D. A., & Mattson, M. P. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104795 · Cited by 188
Self-citationLong-term exercise treatment reduces oxidative stress in the hippocampus of aging rats
Marosi, K., Bori, Z., Hart, N., Sárga, L., Koltai, E., Radák, Z., & Nyakas, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.001 · Cited by 186
Jung, T., Höhn, A., & Grune, T. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.008 · Cited by 185
Adherence to a Mediterranean diet and Alzheimer’s disease risk in an Australian population
Gardener, S., Gu, Y., Rainey-Smith, S. R., Keogh, J. B., Clifton, P. M., Mathieson, S. L., Taddei, K., Mondal, A., Ward, V. K., Scarmeas, N., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.91 · Cited by 185
Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks
Caron, M.-C., Sharma, A. K., O’Sullivan, J., Myler, L. R., Ferreira, M. T., Rodrigue, A., Coulombe, Y., Ethier, C., Gagné, J.-P., Langelier, M.-F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10741-9 · Cited by 185
Identification of oxidized plasma proteins in Alzheimer's disease
Choi, J., Malakowsky, C. A., Talent, J. M., Conrad, C. C., & Gracy, R. W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00420-5 · Cited by 184
Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction
COTMAN, C., HEAD, E., MUGGENBURG, B., ZICKER, S., & MILGRAM, N. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00073-8 · Cited by 184
Oxidative Damage to RNA in Aging and Neurodegenerative Disorders
Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H.-G., Zhu, X., Smith, M. A., & Perry, G. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9331-x · Cited by 183
Jhoo, J. H., Kim, H.-C., Nabeshima, T., Yamada, K., Shin, E.-J., Jhoo, W.-K., Kim, W., Kang, K.-S., Jo, S. A., & Woo, J. I. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.012 · Cited by 183
The mitochondrial theory of aging: Insight from transgenic and knockout mouse models
Jang, Y. C., & Remmen, H. V. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2008.12.006 · Cited by 182
Mechanisms Orchestrating Mitochondrial Dynamics for Energy Homeostasis
Yu, S. B., & Pekkurnaz, G. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.027 · Cited by 182
Selenium and Alzheimer's Disease: A Systematic Review
Loef, M., Schrauzer, G. N., & Walach, H. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110414 · Cited by 181
Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
Self-citationOxidized cholesterol as the driving force behind the development of Alzheimer’s disease
Gamba, P., Testa, G., Gargiulo, S., Staurenghi, E., Poli, G., & Leonarduzzi, G. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00119 · Cited by 180
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells
Su, B., Wang, X., Lee, H.-G., Tabaton, M., Perry, G., Smith, M. A., & Zhu, X. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.010 · Cited by 179
Adaptive Downregulation of Mitochondrial Function in Down Syndrome
Helguera, P., Seiglie, J., Rodriguez, J., Hanna, M., Helguera, G., & Busciglio, J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.005 · Cited by 178
Biasibetti, R., Tramontina, A. C., Costa, A. P., Dutra, M. F., Quincozes-Santos, A., Nardin, P., Bernardi, C. L., Wartchow, K. M., Lunardi, P. S., & Gonçalves, C.-A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.039 · Cited by 176
Efficacy of Sulforaphane in Neurodegenerative Diseases
Schepici, G., Bramanti, P., & Mazzon, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228637 · Cited by 176
Scapagnini, G., Butterfield, D. A., Colombrita, C., Sultana, R., Pascale, A., & Calabrese, V. (2004) · Antioxidants and Redox Signaling · doi:10.1089/1523086041798079 · Cited by 175
Self-citationRedox control of protein degradation
Pajares, M., Jiménez-Moreno, N., Dias, I. H. K., Debelec, B., Vucetic, M., Fladmark, K. E., Basaga, H., Ribaric, S., Milisav, I., & Cuadrado, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.003 · Cited by 172
Mao, P., Manczak, M., Calkins, M. J., Truong, Q., Reddy, T. P., Reddy, A. P., Shirendeb, U., Lo, H.-H., Rabinovitch, P. S., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds128 · Cited by 172
Barone, E., Di Domenico, F., Perluigi, M., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.006 · Cited by 172
Self-citationCell Signaling by Protein Carbonylation and Decarbonylation
Wong, C. M., Marcocci, L., Liu, L., & Suzuki, Y. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2805 · Cited by 170
Moreno, L. C. G. E. I., Puerta, E., Suárez-Santiago, J. E., Santos-Magalhães, N. S., Ramirez, M. J., & Irache, J. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.061 · Cited by 170
Mondragón‐Rodríguez, S., Perry, G. L., Zhu, X., Moreira, P. I., Acevedo, M., & Williams, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/940603 · Cited by 169
Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress
Varadarajan, S., Yatin, S., Kanski, J., Jahanshahi, F., & Butterfield, D. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00093-3 · Cited by 169
Self-citationFemales Live Longer than Males: Role of Oxidative Stress
Vina, J., Gambini, J., Lopez-Grueso, R., M. Abdelaziz, K., Jove, M., & Borras, C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798764942 · Cited by 169
Corcoran, N. M., Martin, D., Hutter-Paier, B., Windisch, M., Nguyen, T., Nheu, L., Sundstrom, L. E., Costello, A. J., & Hovens, C. M. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.04.020 · Cited by 168
Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Perluigi, M., Reed, T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Sultana, R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 168
Self-citationFeng, Z., Chang, Y., Cheng, Y., Zhang, B., Qu, Z., Qin, C., & Zhang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00144.x · Cited by 168
Lipidomics of Alzheimer's disease: current status
Wood, P. L. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt103 · Cited by 167
Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)
Jiang, Y., Sato, Y., Im, E., Berg, M., Bordi, M., Darji, S., Kumar, A., Mohan, P. S., Bandyopadhyay, U., Diaz, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0578-19.2019 · Cited by 166
Boyd-Kimball, D., Sultana, R., Fai Poon, H., Lynn, B. C., Casamenti, F., Pepeu, G., Klein, J. B., & Butterfield, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.022 · Cited by 166
Self-citationNrf2 Suppresses Oxidative Stress and Inflammation in App Knock-In Alzheimer’s Disease Model Mice
Uruno, A., Matsumaru, D., Ryoke, R., Saito, R., Kadoguchi, S., Saigusa, D., Saito, T., Saido, T. C., Kawashima, R., & Yamamoto, M. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00467-19 · Cited by 166
Ebrahimpour, S., Zakeri, M., & Esmaeili, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101095 · Cited by 166
F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo
Praticò, D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00257-9 · Cited by 165
Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models
Gugliandolo, A., Bramanti, P., & Mazzon, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122504 · Cited by 164
Sex Differences in Alzheimer’s Disease: Insights From the Multiomics Landscape
Guo, L., Zhong, M. B., Zhang, L., Zhang, B., & Cai, D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.968 · Cited by 164
Scarpulla, R. C. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.10.011 · Cited by 163
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Limorenko, G., & Lashuel, H. A. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 162
Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers
Peña‐Bautista, C., Baquero, M., Vento, M., & Cháfer‐Pericás, C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.01.021 · Cited by 161
Gaitán, J. M., Moon, H. Y., Stremlau, M., Dubal, D. B., Cook, D. B., Okonkwo, O. C., & van Praag, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.660181 · Cited by 160
Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment
Bayer-Carter, J. L., Green, P. S., Montine, T. J., VanFossen, B. T., Baker, L. D., Watson, G. S., Bonner, L. M., Callaghan, M., Leverenz, J. B., Walter, B. K., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.125 · Cited by 160
Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice
Quinn, J. F., Bussiere, J. R., Hammond, R. S., Montine, T. J., Henson, E., Jones, R. E., & Stackman, R. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.014 · Cited by 160
Dumont, M., Kipiani, K., Yu, F., Wille, E., Katz, M., Calingasan, N. Y., Gouras, G. K., Lin, M. T., & Beal, M. F. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110209 · Cited by 160
Coskun, P. E., Wyrembak, J., Derbereva, O., Melkonian, G., Doran, E., Lott, I. T., Head, E., Cotman, C. W., & Wallace, D. C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100351 · Cited by 159
Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
Miller, E. D., Morel, A., Saso, L., & Saluk, J. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/572491 · Cited by 159
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
Lloret, A., Esteve, D., Monllor, P., Cervera-Ferri, A., & Lloret, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040879 · Cited by 159
Relationship between β-amyloid degradation and the 26S proteasome in neural cells
Lopez Salon, M., Pasquini, L., Besio Moreno, M., Pasquini, J. M., & Soto, E. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00060-2 · Cited by 158
Down Syndrome: From Understanding the Neurobiology to Therapy
Gardiner, K., Hérault, Y., Lott, I. T., Antonarakis, S. E., Reeves, R. H., & Dierssen, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-10.2010 · Cited by 157
Acute neurocognitive effects of epigallocatechin gallate (EGCG)
Scholey, A. B., Downey, L. A., Ciorciari, J., Pipingas, A., Nolidin, K., Finn, M., Wines, M., Catchlove, S. J., Terrens, A., Barlow, E., et al. (2011) · Appetite · doi:10.1016/j.appet.2011.11.016 · Cited by 156
Liu, Z., Li, Z., Liu, L., Tang, W., Wang, Y., Dong, M., & Xiao, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00261 · Cited by 156
Ferretti, M. T., Martínková, J., Biskup, E. M., Benke, T., Gialdini, G., Nedelská, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14174 · Cited by 156
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
Perluigi, M., Pupo, G., Tramutola, A., Cini, C., Coccia, R., Barone, E., Head, E., Butterfield, D. A., & Di Domenico, F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.007 · Cited by 155
Self-citationHudson, D. A., Gannon, S. A., & Thorpe, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.037 · Cited by 155
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
Huynh, K., Lim, W. L. F., Giles, C., Jayawardana, K. S., Salim, A., Mellett, N. A., Smith, A. A. T., Olshansky, G., Drew, B. G., Chatterjee, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19473-7 · Cited by 154
Tiwari, V., Kuhad, A., Bishnoi, M., & Chopra, K. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.05.009 · Cited by 154
Dietary enrichment counteracts age-associated cognitive dysfunction in canines
Milgram, N. W., Zicker, S. C., Head, E., Muggenburg, B. A., Murphey, H. L., Ikeda-Douglas, C. J., & Cotman, C. W. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00020-9 · Cited by 154
Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model
Kim, H. V., Kim, H. Y., Ehrlich, H. Y., Choi, S. Y., Kim, D. J., & Kim, Y. S. (2012) · Amyloid · doi:10.3109/13506129.2012.751367 · Cited by 154
Poon, H. F., Castegna, A., Farr, S. A., Thongboonkerd, V., Lynn, B. C., Banks, W. A., Morley, J. E., Klein, J. B., & Butterfield, D. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.046 · Cited by 154
Self-citationDavies, C. C., & Tournier, C. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110641 · Cited by 153
Lin, T.-W., Shih, Y.-H., Chen, S.-J., Lien, C.-H., Chang, C.-Y., Huang, T.-Y., Chen, S.-H., Jen, C. J., & Kuo, Y.-M. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.12.005 · Cited by 153
Effect of oxidative DNA damage in promoter elements on transcription factor binding
Ghosh, R., & Mitchell, D. L. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.15.3213 · Cited by 152
DNA Oxidation in Alzheimer's Disease
Markesbery, W. R., & Lovell, M. A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2039 · Cited by 151
Holthoff‐Detto, V., Marschner, K., Scharf, M., Steding, J., Meyer, S., Koch, R., & Donix, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121478 · Cited by 151
Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., LaFrancois, J. J., & Duff, K. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00115-4 · Cited by 150
Cellular distribution of superoxide dismutases in the rat CNS
Lindenau, J., Noack, H., Possel, H., Asayama, K., & Wolf, G. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<25::aid-glia3>3.0.co;2-g · Cited by 150
Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice
Schüssel, K., Schäfer, S., Bayer, T. A., Czech, C., Pradier, L., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.003 · Cited by 150
Poon, H. F., Hensley, K., Thongboonkerd, V., Merchant, M. L., Lynn, B. C., Pierce, W. M. J., Klein, J. B., Calabrese, V., & Butterfield, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.030 · Cited by 148
Self-citationChronic Intermittent Fasting Improves Cognitive Functions and Brain Structures in Mice
Li, L., Wang, Z., & Zuo, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066069 · Cited by 147
Karuppagounder, S. S., Xu, H., Shi, Q., Chen, L. H., Pedrini, S., Pechman, D., Baker, H., Beal, M. F., Gandy, S., & Gibson, G. E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.013 · Cited by 147
Glutathione Redox State Regulates Mitochondrial Reactive OxygenProduction
Shen, D., Dalton, T. P., Nebert, D. W., & Shertzer, H. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500095200 · Cited by 147
Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 147
Valenti, D., Manente, G. A., Moro, L., Marra, E., & Vacca, R. A. (2011) · Biochemical Journal · doi:10.1042/bj20101908 · Cited by 144
Kim, S. H., Vlkolinský, R., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01074-8 · Cited by 144
Conti, A. M. F., Fabbrini, F., D'Agostino, P., Negri, R., Greco, D., Genesio, R., D'Armiento, M. R., Olla, C., Paladini, D., Zannini, M., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-268 · Cited by 143
Curcumin effects on blood lipid profile in a 6-month human study
Baum, L., Cheung, S. K. K., Mok, V., Lam, L. C. W., Leung, V., Hui, E., Ng, C., Chow, M., Ho, P. C., & Lam, S. S. L. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.013 · Cited by 142
Oxidative Modification of Proteins: An Emerging Mechanism of Cell Signaling
Wall, S. B., Oh, J., Diers, A. R., & Landar, A. L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00369 · Cited by 142
Remington, R., Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y. M., Smyers, K., Page, R., Morrell, C. H., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142499 · Cited by 141
Role of natural products for the treatment of Alzheimer’s disease
Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141
(1996) · PubMed · Cited by 140
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 140
Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease
Yadav, R. S., & Tiwari, N. K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8661-5 · Cited by 140
The challenge of Down syndrome
Antonarakis, S. E., & Epstein, C. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.08.005 · Cited by 139
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Walgrave, H., Zhou, L., Strooper, B. D., & Salta, E. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00496-7 · Cited by 139
Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging
Cuanalo-Contreras, K., Mukherjee, A., & Soto, C. A. (2013) · International Journal of Cell Biology · doi:10.1155/2013/638083 · Cited by 138
Cysteines as Redox Molecular Switches and Targets of Disease
Fra, A., Yoboue, E. D., & Sitia, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00167 · Cited by 137
Carbonell, T., & Gomes, A. V. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101607 · Cited by 137
Lauderback, C. M., Kański, J., Hackett, J. M., Maeda, N., Kindy, M. S., & Butterfield, D. A. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03228-0 · Cited by 136
Self-citationDixit, S., Bernardo, A., Walker, J. M., Kennard, J. A., Kim, G. Y., Kessler, E. S., & Harrison, F. E. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500308h · Cited by 136
Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo†
Görg, B., Qvartskhava, N., Keitel, V., Bidmon, H. J., Selbach, O., Schliess, F., & Häussinger, D. (2008) · Hepatology · doi:10.1002/hep.22345 · Cited by 136
Knight, A., Bryan, J., & Murphy, K. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.10.005 · Cited by 135
Owen, J. B., Rukhsana Sultana, A., Aluise, C. D., Erickson, M. A., Price, T. O., Bu, G., Banks, W. A., & Butterfield, D. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.013 · Cited by 134
Self-citationJung, T., Höhn, A., & Grune, T. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.029 · Cited by 134
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP
Wiseman, F. K., Pulford, L. J., Barkus, C., Liao, F., Portelius, E., Webb, R., Chávez-Gutiérrez, L., Cleverley, K., Noy, S., Sheppard, O., et al. (2018) · Brain · doi:10.1093/brain/awy159 · Cited by 133
Research works printed but not linked: 13
- 10.1021/ja00731a005 · doi:10.1021/ja00731a005
- 10.1016/j.abb.2022.109117 · doi:10.1016/j.abb.2022.109117
- 10.1016/s0304-3940(97)00341-8 · doi:10.1016/s0304-3940(97)00341-8
- Reed TT, 2010, Neuroproteomics
- 10.1352/0895-8017(2004)109<83:RFFDIP>2.0.CO;2 · doi:10.1352/0895-8017(2004)109<83:rffdip>2.0.co;2
- Zigman WB, 1996, Am J Ment Retard, 100, 403
- Shen YX, 2001, Acta Pharmacol Sin, 22, 797
- Feng HL, 2014, Zhongguo Zhong Yao Za Zhi, 39, 3846
- Veinbergs I, 2000, Eur J Neurosci, 12, 4541
- 10.1016/j.exger.2013.11.008 · doi:10.1016/j.exger.2013.11.008
- 10.1089/ars.2004.6.811 · doi:10.1089/ars.2004.6.811 · Paper page
- He M, 2012, Zhong Yao Cai, 35, 1641
- Abner EL, 2015, J Prev Alzheimers Dis, 2, 11
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
Nixon, R. A., & Rubinsztein, D. C. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00757-5 · Cited by 435
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02095-6 · Cited by 317
Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies
Pappolla, M. A., Martins, R. N., Poeggeler, B., Omar, R. A., & Perry, G. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240659 · Cited by 29
Metadata
- Authors
- Perluigi, M., Di Domenico, F., & Butterfield, D. A.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2024-01-01
- Volume
- 104
- Issue
- 1
- Pages
- 103-197
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W4387660906
- Cited by
- 282
- References
- 751
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Institut Pasteur Fondazione
- Sapienza Università di Roma (RM12117A2EC1C9E4, RM11916B78D5711A, RG1181642744DF59, RG12117A75C98BE3)
- HHS | NIH | National Institute on Aging (AG060056)
- Ministero della Salute (GR-2018-12366381)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.